Tüüp : |
Ajaleht |
Interneti link : |
https://doi.org/10.1016/j.ijpharm.2005.08.007 |
|
Uurimisrühmad : |
Ann Arbor - Pfizer Global Research & Development |
Autor : |
Freed A.L, Silbering S.B, Kolodsick K.J, Rossi D, Mahjour M, Kingsmill C.A. |
Pealkiri : |
The development and stability assessment of extemporaneous pediatric formulations of Accupril. |
Publikatsioon : |
Int J Pharm 304; 1-2: 135-144. 2005 |
|
Tõendite tase : |
|
Füüsikaline stabiilsus : |
|
Keemiline püsivus : |
|
Muud meetodid : |
|
Kommentaarid : |
|
Ingredientide nimekiri
Quinapril
|
|
|
|
|
200 mg Accupril® |
Kphos® |
30 ml |
Bicitra® |
30 ml |
Orasweet® |
>> 200 ml |
|
5°C |
|
42 |
|
|
|
|
|
|
200 mg Accupril® |
Kphos® |
30 ml |
Bicitra® |
30 ml |
Orasweet SF ® |
>> 200 ml |
|
5°C |
|
42 |
|
|
|
|
|
|
200 mg Accupril® |
Kphos® |
30 ml |
Bicitra® |
30 ml |
Lihtsiirup |
>> 200 ml |
|
5°C |
|
42 |
|
|
|
|
|